XML 61 R48.htm IDEA: XBRL DOCUMENT v3.20.4
Shareholders' Equity (Tables)
12 Months Ended
Dec. 31, 2020
Shareholders' Equity  
Summary of the components of accumulated other comprehensive income (loss), net of tax

Accumulated Other Comprehensive Income (Loss)

The following is a summary of the components of accumulated other comprehensive income (loss), net of tax (in millions):

Accumulated

Foreign

Pension

Other

Currency

Liability

Comprehensive

    

Translation

    

Adjustment

    

Income (Loss)

Balance at December 31, 2017

$

72.2

(45.2)

27.0

Other comprehensive income

 

(25.3)

11.9

(13.4)

Realized loss on reclassification

 

3.4

3.4

Balance at December 31, 2018

 

46.9

(29.9)

17.0

Other comprehensive income (loss)

 

(19.5)

(25.1)

(44.6)

Realized loss on reclassification

 

2.1

2.1

Balance at December 31, 2019

27.4

$

(52.9)

$

(25.5)

Other comprehensive income

 

22.0

2.3

24.3

Realized loss on reclassification

 

4.9

4.9

Balance at December 31, 2020

$

49.4

$

(45.7)

$

3.7

Schedule of the impact of stock-based compensation expense

The following presents the impact of stock-based compensation expense on our consolidated statements of income (in millions):

2020

2019

2018

Stock options

    

$

1.8

    

$

2.7

    

$

4.2

Restricted stock awards

 

 

0.3

 

0.8

Restricted stock units

 

11.5

 

8.9

 

6.3

Total stock-based compensation

$

13.3

$

11.9

$

11.3

2020

2019

2018

Costs of product revenue

    

$

2.0

    

$

1.8

    

$

1.7

Selling, general and administrative

 

9.3

 

8.3

 

7.9

Research and development

 

2.0

 

1.8

 

1.7

Total stock-based compensation

$

13.3

$

11.9

$

11.3

Schedule of stock option activity

Stock option activity is as follows:

    

    

    

Weighted -

    

Average

Weighted-

Remaining

Aggregate

Number of

Average Price

Contractual

Intrinsic Value

Options

Per Share

Term (in Years)

(in millions) (a)

Outstanding at December 31, 2019

 

1,988,696

$

23.43

 

4.9

$

54.8

Granted

 

125,794

45.54

Exercised

 

(241,915)

20.29

Forfeited/Expired

 

(16,399)

20.98

Outstanding at December 31, 2020

 

1,856,176

$

25.32

4.2

$

53.5

Exercisable at December 31, 2020

 

1,546,061

$

22.14

3.9

$

49.5

Exercisable and expected to vest at December 31, 2020 (b)

 

1,818,104

$

24.95

4.2

$

53.1

(a)Represents the number of vested options at December 31, 2020, plus the number of unvested options at December 31, 2020 that are ultimately expected to vest based on our estimated forfeiture rate.
(b)The aggregate intrinsic value is calculated as the positive difference between the exercise price of the underlying options and the quoted price of our common stock on December 31, 2020.
Schedule of Unvested restricted stock unit activity

Unvested restricted stock unit activity is presented below:

Weighted-

Average Grant

Shares

Date Fair

Subject to

    

Value

    

Restriction

Per Share

Outstanding at December 31, 2019

 

865,101

$

34.73

Granted

336,341

43.96

Vested

 

(336,728)

32.00

Forfeited

(59,662)

35.99

Outstanding at December 31, 2020

 

805,052

$

39.63